The National Heart, Lung, and Blood Institute has granted $14.4 million for the study of hypertrophic cardiomyopathy in an effort to identify the highest-risk patients. The University of Virginia School of Medicine and the University of Oxford will lead the effort, which will examine imaging, genetic and other predictive tools as well as demographics and clinical variables.

Related Summaries